Preview: Unitil’s Earnings

Unitil (NYSE:UTL) is set to give its latest quarterly earnings report on Tuesday, 2024-02-13. Here’s what investors need…

Unitil (NYSE:UTL) is set to give its latest quarterly earnings report on Tuesday, 2024-02-13. Here’s what investors need to know before the announcement.

Analysts estimate that Unitil will report an earnings per share (EPS) of $0.93.

Unitil bulls will hope to hear the company announce they’ve not only beaten that estimate, but also to provide positive guidance, or forecasted growth, for the next quarter.

New investors should note that it is sometimes not an earnings beat or miss that most affects the price of a stock, but the guidance (or forecast).

Past Earnings Performance

Last quarter the company beat EPS by $0.03, which was followed by a 1.07% drop in the share price the next day.

Here’s a look at Unitil’s past performance and the resulting price change:

Quarter Q3 2023 Q2 2023 Q1 2023 Q4 2022
EPS Estimate 0.06 0.27 1.45 0.90
EPS Actual 0.09 0.25 1.51 0.91
Price Change % -1.07% 0.14% -0.16% 4.74%

eps graph

Stock Performance

Shares of Unitil were trading at $48.57 as of February 09. Over the last 52-week period, shares are down 3.87%. Given that these returns are generally negative, long-term shareholders are likely bearish going into this earnings release.

To track all earnings releases for Unitil visit their earnings calendar on our site.

This article was generated by Benzinga’s automated content engine and reviewed by an editor.

Total
0
Shares
Related Posts
Read More

Entourage Health Cannabis Reports 9% YoY Increase In Q1 Revenue, Positive EBITDA And ‘Substantial Growth’

Canadian cannabis producer and distributor Entourage Health Corp. (TSX-V: ENTG) (OTCQX: ETRGF) (FSE:4WE) announced on Tuesday its first quarter financial results for the three months ended March 31, 2024. The Toronto-based company reported a total revenue of CA$16.4 million ($12 million) (net revenue of CA$12.7 million, before excise duties and discounts), representing a 9% year-over-year increase. "Entourage's first quarter results are a testament to our robust financial health and strategic approach to business operations, positioning us for success throughout 2024," George Scorsis, the company's chair and CEO, said. "With defined infrastructure and supply agreements in place, we are well-positioned to continue delivering the accelerated growth we have already seen develop in Q1."

ETRGF